T1	Participants 120 154	breathlessness in advanced disease
T2	Participants 394 457	breathless patients with advanced disease (regardless of cause)
T3	Participants 1097 1258	patients with malignant disease (intervention delivered over two weeks) and one for patients with non-malignant disease (intervention delivered over four weeks).
T4	Participants 1328 1456	patients with malignant conditions (four week protocol) and one for patients with non-malignant conditions (eight week protocol)
T5	Participants 1994 2021	breathlessness intervention
T6	Participants 2026 2042	advanced disease
